Psilocybin, the hallucinogenic ingredient in "magic" mushrooms, has been studied. Mice given low doses of the drug stopped freezing earlier in the experiment. This suggests the drug can have positive psychiatric effects.
Original Description:
Original Title
Could “Magic” Mushrooms Be Used to Treat Anxiety & Depression_ _Higher Perspective
Psilocybin, the hallucinogenic ingredient in "magic" mushrooms, has been studied. Mice given low doses of the drug stopped freezing earlier in the experiment. This suggests the drug can have positive psychiatric effects.
Psilocybin, the hallucinogenic ingredient in "magic" mushrooms, has been studied. Mice given low doses of the drug stopped freezing earlier in the experiment. This suggests the drug can have positive psychiatric effects.
Emerging research indicates that low doses of the active chemical psilocybin can have positive psychiatric effects. Photo: John Downing In the 1960s and early 70s, researchers such as Harvards Timothy Leary enthusiastically promoted the study of so-called magic mushrooms (formally known as psilocybin mushrooms) and championed their potential benefits for psychiatry. For a brief moment, it seemed that controlled experiments with mushrooms and other psychedelics would enter the scientific mainstream. Then, everything changed. A backlash against the 1960s drug culturealong with Leary himself, who was arrested for drug possessionmade research nearly impossible. The federal HOME / SCIENCE / COULD MAGIC MUSHROOMS BE USED TO TREAT ANXIETY & DEPRESSION? MENU government criminalized mushrooms, and research ground to a halt for over 30 years. But recently, over the past few years, the pendulum has swung back in the other direction. And now, new research into the mind-altering chemical psilocybin in particularthe hallucinogenic ingredient in magic mushroomshas indicated that carefully controlled, low doses of it might be an effective way of treating people with clinical depression and anxiety. The latest study, published last week in Experimental Brain Research, showed that dosing mice with a purified form of psilocybin reduced their outward signs of fear. The rodents in the study had been conditioned to associate a particular noise with the feeling of being electrically shocked, and all the mice in the experiment kept freezing in fear when the sound was played even after the shocking apparatus was turned off. Mice who were given low doses of the drug, though, stopped freezing much earlier on, indicating that they were able to disassociate the stimuli and the negative experience of pain more easily. Psilocybin, the active chemical in hallucinogenic mushrooms. (Black = carbon atoms, white = hydrogen, red = oxygen, blue = nitrogen, and orange = phosphorus.) Image via Wikimedia Commons/Jynto Its difficult to ask a tortured mouse why exactly it feels less fearful (and presumably even more difficult when that mouse is in the midst of a mushroom trip). But a handful of other recent studies have demonstrated promising effects of psilocybin on a more communicative group of subjects: humans. In 2011, a study published in the Archives of General Psychiatry by researchers from UCLA and elsewhere found that low doses of psilocybin improved the moods and reduced the anxiety of 12 late- stage terminal cancer patients over a long period. These were patients aged 36 to 58 who suffered from depression and had failed to respond to conventional medications. Each patient was given either a pure dose of psilocybin or a placebo, and asked to report their levels of depression and anxiety several times over the next few months. Those whod been dosed with psilocybin had lower anxiety levels at one and three months, and reduced levels of depression starting two weeks after treatment and continuing for a full six months, the entire period covered by the study. Additionally, carefully administering low doses and controlling the environment prevented any participants from having a negative experience while under the influence (colloquially, a bad trip.) A research group from Johns Hopkins has conducted the longest- running controlled study of the effects of psilocybin, and their findings might be the most promising of all. In 2006, they gave 36 healthy volunteers (whod never before tried hallucinogens) a dose of the drug, and 60 percent reported having a full mystical experience. 14 months later, the majority reported higher levels of overall well-being than before and ranked taking psilocybin as one of the five most personally significant experiences of their lives. In 2011, the team conducted a study with a separate group, and when members of that group were questioned a full year later, the researchers found that according to personality tests, the participants openness to new ideas and feelings had increased significantlya change seldom seen in adults had increased. Psilocybe cubensis is the most common species of psilocybin mushrooms. Image via Wikimedia Commons/Wowbobwow12 As with many questions involving the functioning of the mind, scientists are still in the beginning stages of figuring out whether and how psilocybin triggers these effects. We do know that soon after psilocybin is ingested (whether in mushrooms or in a purified form), its broken down into psilocin, which stimulates the brains receptors for serotonin, a neurotransmitter believed to promote positive feelings (and also stimulated by conventional anti- depressant drugs). Imaging of the brain on psilocybin is in its infancy. A 2012 study in which volunteers were dosed while in an fMRI (functional magnetic resonance imaging) machine, which measures blood flow to various parts of the brain, indicated that the drug decreased activity in a pair of hub areas (the medial prefrontal cortex and posterior cingulate cortex), which have dense concentrations of connections with other areas in the brain. These hubs constrain our experience of the world and keep it orderly, David Nutt, a neurobiologist at the Imperial College London and lead author, said at the time. We now know that deactivating these regions leads to a state in which the world is experienced as strange. Its unclear how this could help with depression and anxiety or whether its simply an unrelated consequences of the drug that has nothing to do with its beneficial effects. Regardless, the push for more research into the potential applications of psilocybin and other hallucinogens is clearly underway. Wired recently profiled the roughly 1,600 scientists who attended the 3rd annual Psychedelic Science meeting, many of which are studying psilocybinalong with other drugs like LSD (a.k.a. acid) and MDMA (a.k.a. ecstasy). Of course, theres an obvious problem with using psilocybin mushrooms as medicineor even researching its effects in a lab setting. Currently, in the U.S., theyre listed as a Schedule I controlled substance, meaning that theyre illegal to buy, possess, use or sell, and cant be prescribed by a doctor, because they have no accepted medical use. The research that has occurred went on under strict government supervision, and getting approval for new studies is notoriously difficult. That said, the fact that research is occurring at all is an obvious sign that things are slowly changing. The idea that medicinal use of marijuana would one day be permitted in dozens of states would have once seemed far-fetchedso perhaps its not entirely absurd to suggest that medicinal mushrooms could be next. Source: Smithsonian Mag My Science Academy
2
StumbleUpon Submit Tweet 14
5.4k Like 4 Popular Content Probiotics: The Surprising New Way to Lose Weight New Tech Lets You Speak a Language in 10 Days Tricks Car Insurance Agents Don't Want You to Know Why Snoring Can Kill - and How to Stop It Find Out if Any of Your Ancestors Were Famous - What Happens When You Take a Testosterone Rare Discovery Helps Lower Blood Pressure How to Get Freakishly Long Eyelashes in 7 Days ? Facebook social plugin Comment Posting as Mihai Munteanu (Not you?) Add a comment... Also post on Facebook
Rosemarie Eagle FYI ! Reply Like Follow Post December 9, 2013 at 11:57pm 2 Mike Fryberger The Old School Of Hard Knocks I'll take a pound! lol Reply Like December 10, 2013 at 12:25am Laura Harvey Dallas, Texas Looking at a perspective as a medicinal alternative, I question the aspect of this as being saf e. If people drink and drive it causes serious consequences, as well as hazardous to your liver. Theref ore, even small doses of mind altering substances could prove deadly driving a vehicle. While marajuana may slow reaction time, I think it would be a saf er alternative. Rd Reply Like Follow Post November 13, 2013 at 2:08am 1 Kathy Willis Stockton, Calif ornia Just move to Calif ornia.lol Reply Like November 13, 2013 at 3:44am Saenen Laurent OSG De Meergronden Marihuana is NOT a good idea to treat anxiety or depressions, it can even cause it!!!! The main argument against marijuana is that it does not produce Serotonin, but af f ects anandamide which is present in brain and produces soothing f eeling by reacting with THC which is present in marijuana. This can actually increase the depression and cause schizophrenia like in regular illegal use af ter a prolonged use. It is always saf e to administer antidepressant under medical care than use the illegal substance. Also, the constituents of marijuana interf ere with the process of balancing the chemicals which antidepressants work to achieve and in f act it may aggravate the condition instead of curing it. Reply Like Follow Post December 8, 2013 at 10:42pm Higher Perspective You like this. You and 309,513 others like Higher Perspective Facebook social plugin Like 3 Herbs that Beat Anxiety www.a2xanxiety.com Doctors Reveal 1 Weird Compound to Calm Anxiety that May Surprise You HIGHER MISSION Currently Higher Perspective is seeking contributing authors, advertising partners, and strategic product offerings. Reach out to join the team. NEWS 10 Reasons You Should Never Get a Job 14 OCT 2013 8 Great Philosophical Questions That We'll Never Solve 28 APR 2013 HEADLINES Is The Internet Turning Us Into Buddhas? Can Psychedelic Mushrooms Cure Cigarette Addiction? How To Live Like A King For Very Little CONTACT US Currently Higher Perspective is seeking contributing authors, advertising partners, and strategic product offerings. Reach out to join the team. ALL OUR MISSION CONTACT SITE BY THE PIXEL FLOW